[{"AccountsPayableCurrent_0_Q1_USD":1357000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":918000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":1411000.0,"OtherReceivablesNetCurrent_0_Q1_USD":156000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":918000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":133834000.0,"PrepaidInsurance_0_Q1_USD":582000.0,"OtherAssetsCurrent_0_Q1_USD":617000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":55000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":5640000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":927085000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":115000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":8782000.0,"OtherAssetsNoncurrent_0_Q1_USD":662000.0,"NonoperatingIncomeExpense_1_Q1_USD":-15699000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":12000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-13994000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q1_USD":3188000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-46000.0,"LeaseCost_1_Q1_USD":73000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.88,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.9,"OtherNoncashIncomeExpense_1_Q1_USD":-2000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.065,"OperatingLeaseRightOfUseAsset_0_Q1_USD":547000.0,"OperatingLeasePayments_1_Q1_USD":52000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":298000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":175000.0,"OperatingLeaseLiability_0_Q1_USD":473000.0,"OperatingLeaseCost_1_Q1_USD":51000.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":132963000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":42000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":150000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":203000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":162000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":515000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-1522000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.006,"OtherNonoperatingIncomeExpense_1_Q1_USD":541000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":15886314.0,"LiabilitiesCurrent_0_Q1_USD":6997000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":136791000.0,"Liabilities_0_Q1_USD":7295000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-429000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":357000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":78000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-31834000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4544000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.14,"Depreciation_1_Q1_USD":13000000.0,"CommonStockValue_0_Q1_USD":10000.0,"CommonStockSharesOutstanding_0_Q1_shares":1867176.0,"CommonStockSharesIssued_0_Q1_shares":10395732.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":133534000.0,"AssetsCurrent_0_Q1_USD":135470000.0,"Assets_0_Q1_USD":136791000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":12842917000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13948000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":16240000.0,"NetIncomeLoss_1_Q1_USD":-31912000.0,"ProfitLoss_1_Q1_USD":-31912000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1162000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":568000.0,"Cash_0_Q1_USD":571000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":456000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":918000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":11591000.0,"OperatingIncomeLoss_1_Q1_USD":-16135000.0,"OperatingExpenses_1_Q1_USD":16135000.0,"IncomeTaxesPaidNet_1_Q1_USD":14000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":10156628.0,"StockholdersEquity_0_Q1_USD":129496000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-797599000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":112000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1936000.0,"ShortTermLeaseCost_1_Q1_USD":22000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]